Abstract
Cerebral microbleeds (CMB) are small MRI signal voids due to tiny hemosiderin deposits derived from red blood cell extravasation. The relationship between CMB and postthrombolysis intracerebral hemorrhage (ICH), the most feared complication of thrombolysis for acute ischemic stroke, has received considerable attention. Individual studies relating CMB and postthrombolysis ICH have generally failed to show a significant association. However, recent meta-analyses indicate that CMB presence or burden on pretreatment MRI is associated with postthrombolysis ICH. The exact nature of the CMB–postthrombolysis ICH relationship is complicated by the heterogeneous nature of CMB and their associated risk factors hypertension, cerebral amyloid angiopathy, and chronic kidney disease. CMB may be due to a primary disruption of the vessel wall (primary CMB) or may be a consequence of ischemic brain injury (secondary CMB). Clinicians making decisions regarding whether or not to offer intravenous thrombolysis to patients with acute ischemic stroke should attempt to distinguish primary from secondary CMB, as it is the former that likely create the greatest risk for postthrombolysis ICH.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
del Zoppo GJ, Saver JL, Jauch EC, Adams HP (2009) Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke 40:2945–2948
Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC et al (2010) Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 375:1695–1703
Mullen MT, Pisapia JM, Tilwa S, Messe SR, Stein SC (2012) Systematic review of outcome after ischemic stroke due to anterior circulation occlusion treated with intravenous, intra-arterial, or combined intravenous intra-arterial thrombolysis. Stroke 43:2350–2355
Derex L, Nighoghossian N (2008) Intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: an update. J Neurol Neurosurg Psychiatry 79:1093–1099
Charidimou A, Kakar P, Fox Z, Werring DJ (2013) Cerebral microbleeds and the risk of intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 84:277–280
Shoamanesh A, Kwok CS, Lim PA, Benavente OR (2013) Postthrombolysis intracranial hemorrhage risk of cerebral microbleeds in acute stroke patients: a systematic review and meta-analysis. Int J Stroke 8(5):348–356
Greenberg SM, Vernooij MW, Cordonnier C, Viswanathan A, Al-Shahi Salman R, Warach S et al (2009) Cerebral microbleeds: a field guide to detection and interpretation. Lancet Neurol 8:165–174
Cordonnier C, Al-Shahi Salman R, Wardlaw J (2007) Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting. Brain 130:1988–2003
Gregoire SM, Chaudhary UJ, Brown MM, Yousry TA, Kallis C, Jager HR et al (2009) The Microbleed Anatomical Rating Scale (MARS): reliability of a tool to map brain microbleeds. Neurology 73(21):1759–1766
Cordonnier C, Potter GM, Jackson CA et al (2009) Improving inter-rater agreement about brain microbleeds: development of the Brain Observer MicroBleed Scale (BOMBS). Stroke 40:94–99
Vernooij MW, van der Lugt A, Ikram MA, Wielopolski PA, Niessen WJ, Hofman A et al (2008) Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology 70:1208–1214
Fazekas F, Kleinert R, Roob G, Kleinert G, Kapeller P, Schmidt R et al (1999) Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy related microbleeds. AJNR Am J Neuroradiol 20:637–642
Schrag M, McAuley G, Pomakian J, Jiffry A, Tung S, Mueller C et al (2010) Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study. Acta Neuropathol (Berl) 119:291–302
Haacke EM, DelProposto ZS, Chaturvedi S, Sehgal V, Tenzer M, Neelavalli J et al (2007) Imaging cerebral amyloid angiopathy with susceptibility-weighted imaging. AJNR Am J Neuroradiol 28:316–317
Fisher M (2014) Cerebral microbleeds: where are we now? Neurology 83:1304–1305
Jeon SB, Kwon SU, Cho AH, Yun SC, Kim JS, Kang DW (2009) Rapid appearance of new cerebral microbleeds after acute ischemic stroke. Neurology 73:1638–1644
Tanskanen M, Mäkelä M, Myllykangas L, Rastas S, Sulkava R, Paetau A (2012) Intracerebral hemorrhage in the oldest-old: a population-based study (Vantaa 851). Front Neurol 3:103
Fisher M, French S, Ji P, Kim RC (2010) Cerebral microbleeds in the elderly: a pathological analysis. Stroke 41:2782–2785
Janaway BM, Simpson JE, Hoggard N et al (2014) Brain haemosiderin in older people: pathological evidence for an ischaemic origin of magnetic resonance imaging (MRI) microbleeds. Neuropathol Appl Neurobiol 40:258–269
Wahlgren N, Ahmed N, Davalos A, Ford GA, Grond M, Hacke W (2007) Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 369:275–282
Trouillas P, von Kummer R (2006) Classification and pathogenesis of cerebral hemorrhages after thrombolysis in ischaemic stroke. Stroke 37:556–561
Gao Y, Churilov L, Teo S, Yan B (2015) Remote intracerebral haemorrhage post intravenous thrombolysis: experience from an Australian stroke centre. J Clin Neurosci 22(2):352–356
Mazya MV, Ahmed N, Ford GA, Hobohm C, Mikulik R, Nunes AP et al (2014) Remote or extraischemic intracerebral hemorrhage–an uncommon complication of stroke thrombolysis: results from the safe implementation of treatments in stroke-international stroke thrombolysis register. Stroke 45:1657–1663
Shoamanesh A, Yan S, Charidimou A (2015) New cerebral microbleeds and mechanism of post-thrombolysis remote intracerebral hemorrhage: “red meets white” revisited. Front Neurol 6:203
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581–1587
Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D et al (1998) Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASSII). Lancet 352:1245–1251
Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S (1999) Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset: the ATLANTIS Study, a randomized controlled trial: alteplase thrombolysis for acute noninterventional therapy in ischemic stroke. JAMA 21:2019–2026
Pantoni L, Fierini F, Poggesi A (2014) Thrombolysis in acute stroke patients with cerebral small vessel disease. Cerebrovasc Dis 37(1):5–13
Werring DJ, Gregoire SM, Cipolotti L (2010) Cerebral microbleeds and vascular cognitive impairment. J Neurol Sci 299(1–2):131–135
Neumann-Haefelin T, Hoelig S, Berkefeld J, Fiehler J, Gass A, Humpich M, Kastrup A et al (2006) Leukoaraiosis is a risk factor for symptomatic intracerebral hemorrhage after thrombolysis for acute stroke. Stroke 37:2463–2466
Palumbo V, Boulanger JM, Hill MD, Inzitari D, Buchan AM (2007) Leukoaraiosis and intracerebral hemorrhage after thrombolysis in acute stroke. Neurology 68:1020–1024
Aries MJH, Uyttenboogaart M, Vroomen PC, de Keyser J, Luijckx GJ (2010) tPA treatment for acute ischaemic stroke in patients with leukoaraiosis. Eur J Neurol 17:866–870
Shi ZS, Loh Y, Liebeskind DS, Saver JL, Gonzalez NR, Tateshima S et al (2012) Leukoaraiosis predicts parenchymal hematoma after mechanical thrombectomy in acute ischemic stroke. Stroke 43:1806–1811
Charidimou A, Shoamanesh A, Wilson D, Gang Q, Fox Z, Jäger HR et al (2015) Cerebral microbleeds and postthrombolysis intracerebral hemorrhage risk updated meta-analysis. Neurology 85(11):927–934
Tsivgoulis G, Zand R, Katsanos AH, Turc G, Nolte CH, Jung S et al (2016) Risk of symptomatic intracerebral hemorrhage after intravenous thrombolysis in patients with acute ischemic stroke and high cerebral microbleed burden: a meta-analysis. JAMA Neurol 73(6):675–683 (published online April 18, 2016)
Dannenberg S, Scheitz JF, Rozanski M, Erdur H, Brunecker P, Werring DJ et al (2014) Number of cerebral microbleeds and risk of intracerebral hemorrhage after intravenous thrombolysis. Stroke 45:2900–2905
Derex L, Nighoghossian N, Hermier M, Adeleine P, Philippeau F, Honnorat J et al (2004) Thrombolysis for ischemic stroke in patients with old microbleeds on pretreatment MRI. Cerebrovasc Dis 17:238–241
Kakuda W, Thijs VN, Lansberg MG, Bammer R, Wechsler L, Kemp S et al (2005) Clinical importance of microbleeds in patients receiving IV thrombolysis. Neurology 65:1175–1178
Fiehler J, Albers GW, Boulanger JM, Derex L, Gass A, Hjort N et al (2007) Bleeding Risk Analysis in Stroke Imaging Before Thrombolysis (BRASIL): pooled analysis of T2*-weighted magnetic resonance imaging data from 570 patients. Stroke 38:2738–2744
Kimura K, Aoki J, Shibazaki K, Saji N, Uemura J, Sakamoto Y (2013) New Appearance of extraischemic microbleeds on T2*-weighted magnetic resonance imaging 24 hours after tissue-type plasminogen activator administration. Stroke 44:2776–2781
Gratz PP, El-Koussy M, Hsieh K, von Arx S, Mono ML, Heldner MR et al (2014) Preexisting cerebral microbleeds on susceptibility-weighted magnetic resonance imaging and post-thrombolysis bleeding risk in 392 patients. Stroke 45:1684–1688
Kidwell CS, Saver JL, Villablanca JP, Duckwiler G, Fredieu A, Gough K et al (2002) Magnetic resonance imaging detection of microbleeds before thrombolysis: an emerging application. Stroke 33:95–98
Kim HS, Lee DH, Ryu CW, Lee JH, Choi CG, Kim SJ et al (2006) Multiple cerebral microbleeds in hyperacute ischemic stroke: impact on prevalence and severity of early hemorrhagic transformation after thrombolytic treatment. AJR Am J Roentgenol 186:1443–1449
Moriya Y, Takahashi W, Kijima C et al (2013) Predictors for hemorrhagic transformation with intravenous tissue plasminogen activator in acute ischemic stroke. Tokai J Exp Clin Med 38:24–27
Yan SQ, Wan JP, Guo Y, Lou M (2014) Impact of cerebral microbleeds on outcomes of acute ischemic stroke treated with intravenous thrombolysis (in Chinese). Zhejiang Da Xue Xue Bao Yi Xue Ban 43:20–27
Yan S, Jin X, Zhang X, Zhang S, Liebeskind DS, Lou M (2015) Extensive cerebral microbleeds predict parenchymal haemorrhage and poor outcome after intravenous thrombolysis. J Neurol Neurosurg Psychiatry 86(11):1267–1272
Goyal N, Tsivgoulis G, Male S, Bhaskaran D, Alexandrov AV, Zand R (2015) Feasibility of rapid short sequence magnetic resonance imaging for screening stroke mimics within the iv-tpa treatment window: a pilot study. Poster presented at international stroke conference 2015; February 11–12, 2015; Nashville
Turc G, Sallem A, Moulin S, Tisserand M, Machet A, Edjlali M et al (2015) Microbleed status and 3-month outcome after intravenous thrombolysis in 717 patients with acute ischemic stroke. Stroke 46(9):2458–2463
Fisher M (2016) Cerebral microbleeds and thrombolysis: clinical consequences and mechanistic implications. JAMA Neurol 73(6):632–635. doi:10.1001/jamaneurol.2016.0576 (Epub ahead of print)
Disclosures
Supported by NIH NS 20989
Dr. Fisher receives research support from Boehringer-Ingelheim and Otsuka Pharmaceutical Company, and serves on Clinical Events Committees for Covidien.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Lee, J., Fisher, M. (2017). Cerebral Microbleeds and Thrombolysis for Acute Ischemic Stroke. In: Lapchak, P., Zhang, J. (eds) Neuroprotective Therapy for Stroke and Ischemic Disease. Springer Series in Translational Stroke Research. Springer, Cham. https://doi.org/10.1007/978-3-319-45345-3_21
Download citation
DOI: https://doi.org/10.1007/978-3-319-45345-3_21
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-45344-6
Online ISBN: 978-3-319-45345-3
eBook Packages: MedicineMedicine (R0)